The Sclera pp 171-241 | Cite as

Noninfectious Scleritis: The Massachusetts Eye and Ear Infirmary Experience

  • C. Stephen Foster
  • Maite Sainz de la Maza


The intrinsic nature of scleritis poses an ultimate challenge to the skill of the managing ophthalmologist. The chronicity of the disease, its tendency to exacerbate and remit, its relationship with many ocular and systemic diseases, and its variable response to specific treatment combine to complicate management.


Systemic Lupus Erythematosus Ankylose Spondylitis Systemic Lupus Erythematosus Patient Giant Cell Arteritis Anterior Uveitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Harris ED: Rheumatoid arthritis: the clinical spectrum. In Kelley WN, Harris ED, Ruddy S, Sledge CB: Textbook of Rheumatology, 3rd ed. W.B. Saunders, Philadelphia, 1989, pp 915–949.Google Scholar
  2. 2.
    Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS: HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32: 15, 1989.PubMedCrossRefGoogle Scholar
  3. 3.
    Jacoby RK, Jayson MIV, Cosh JA: Onset, early stages and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11 year follow-up. Br Med J 2: 96, 1973.PubMedCrossRefGoogle Scholar
  4. 4.
    Fleming A, Crown JM, Corbett M: Early rheumatoid disease. I. Onset. Ann Rheum Dis 35: 357, 1976.CrossRefGoogle Scholar
  5. 5.
    Fleming A, Benn RT, Corbett M, Wood PH: Early rheumatoid disease. II. Patterns of joint involvement. Ann Rheum Dis 35: 361, 1976.PubMedCrossRefGoogle Scholar
  6. 6.
    Hurd ER: Extra-articular manifestations of rheumatoid arthritis. Semin Rheum Dis 8: 151, 1979.CrossRefGoogle Scholar
  7. 7.
    Hart FD: Rheumatoid arthritis. Extra-articular manifestations. Br Med J 3: 131, 1969.PubMedCrossRefGoogle Scholar
  8. 8.
    Sharp JT, Calkins E, Cohen AS, Schubart AF, Calabro JJ: Observations on the clinical, chemical, and serologic manifestations of rheumatoid arthritis based on the course of 154 patients. Medicine 43: 41, 1964.PubMedCrossRefGoogle Scholar
  9. 9.
    Masi AT, Maldonado-Cocco JA, Kaplan SB, Feigenbaum SL, Chandler RW: Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome. Semin Arthritis Rheum 5: 299, 1976.CrossRefGoogle Scholar
  10. 10.
    Talbott JH, Altman RD, Yu TF: Gouty arthritis masquerading as rheumatoid arthritis or vice versa. Semin Arthritis Rheum 8: 77, 1978.PubMedCrossRefGoogle Scholar
  11. 11.
    Khachadurian AK: Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia). Arthritis Rheum 2: 385, 1968.CrossRefGoogle Scholar
  12. 12.
    Wiernik PH: Amyloid joint disease. Medicine (Baltimore) 51: 465, 1971.Google Scholar
  13. 13.
    Gordon DA, Pruzanski W, Ogyzlo MA, Little HA: Amyloid arthritis simulating rheumatoid disease in five patients with multiple myeloma. Am J Med 55: 142, 1973.PubMedCrossRefGoogle Scholar
  14. 14.
    Healey LA, Wilske KR, Sagebiel RW: Rheumatoid nodules simulating basal-cell carcinoma. N Engl J Med 277: 7, 1967.PubMedCrossRefGoogle Scholar
  15. 15.
    Wood MG, Beerman H: Necrobiosis lipoidica, granuloma anulare. Report of a case with lesions in the galea aponeurotica of a child. Am J Dis Child 96: 720, 1958.Google Scholar
  16. 16.
    Hahn BH, Yardley JH, Stevens MB: “Rheumatoid” nodules in systemic lupus erythematosus. Ann Intern Med 72: 49, 1970.PubMedGoogle Scholar
  17. 17.
    Dubois EL, Friou GJ, Chandor S: Rheumatoid nodules and rheumatoid granulomas in systemic lupus erythematosus. JAMA 220: 515, 1972.PubMedCrossRefGoogle Scholar
  18. 18.
    Barrow MV, Holubar K: Multicentric reticulohistiocytosis: a review of 33 patients. Medicine (Baltimore) 48: 287, 1969.CrossRefGoogle Scholar
  19. 19.
    Cats A, Hazevoet HM: Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. Ann Rheum Dis 29: 254, 1970.PubMedCrossRefGoogle Scholar
  20. 20.
    Mongan ES, Cass RM, Jacox RF, Vaughan JH: A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med 47: 23, 1969.PubMedCrossRefGoogle Scholar
  21. 21.
    Turner R, Collins R, Nomeir AM: Extra-articular manifestations of rheumatoid arthritis. Bull Rheum Dis 29: 986, 1978–1979.Google Scholar
  22. 22.
    Sokoloff L, Bunim JJ: Vascular lesions in rheumatoid arthritis. J Chron Dis 5: 668, 1957.PubMedCrossRefGoogle Scholar
  23. 23.
    Duthie JJR, Brown PE, Truelove LH, Barago E, Lawrie AJ: Course and prognosis in rheumatoid arthritis. A further report. Ann Rheum Dis 23: 193, 1964.PubMedCrossRefGoogle Scholar
  24. 24.
    Ragan C, Farrington E: The clinical features of rheumatoid arthritis. JAMA 181: 663, 1962.PubMedCrossRefGoogle Scholar
  25. Scott JT, Hourhane DO, Doyle FH: Digital arteritis in rheumatoid disease. Ann Rheum Dis 20:224, 1961.Google Scholar
  26. 26.
    Schmid FR, Cooper NS, Ziff M, McEweh C: Arteritis in rheumatoid arthritis. Am J Med 30: 56, 1961.PubMedCrossRefGoogle Scholar
  27. 27.
    Bienenstock H, Minick R, Rogoff B: Mesenteric arteritis and intestinal infarction in rheumatoid disease. Arch Intern Med 119: 359, 1967.PubMedCrossRefGoogle Scholar
  28. 28.
    Voyles WF, Searles RP, Bankhurst AD: Myocardial infarction caused by rheumatoid vasculitis. Arthritis Rheum 23 (7): 860, 1980.PubMedCrossRefGoogle Scholar
  29. 29.
    Fong LP, Sainz de la Maza M, Rice BA, Foster CS. Immunopathology of scleritis. Ophthalmology 98: 472, 1991.PubMedGoogle Scholar
  30. 30.
    Scott DG, Bacon PA, Tribe CR: Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 60 (4): 288, 1981.Google Scholar
  31. 31.
    Scott DGI, Bacon PA, Allen C, Elson CJ, Wallington T: IgG rheumatoid factor, complement, and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 43: 54, 1981.PubMedGoogle Scholar
  32. 32.
    Hunder GG, McDuffie FC: Hypocomplementinemia in rheumatoid arthritis. Am J Med 54: 461, 1973.PubMedCrossRefGoogle Scholar
  33. 33.
    Scott DGI, Bacon PA, Elliott PJ, Tribe CR, Wallington TB: Systemic vasculitis in a district general hospital 1972–80: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 51: 292, 1982.PubMedGoogle Scholar
  34. 34.
    Ferguson RH, Slocumb CH: Peripheral neuropathy in rheumatoid arthritis. Bull Rheum Dis 11: 251, 1961.PubMedGoogle Scholar
  35. 35.
    Walker WC, Wright V: Pulmonary lesions and rheumatoid arthritis. Medicine 47: 501, 1968.PubMedCrossRefGoogle Scholar
  36. 36.
    Dodson WH, Hollingsworth JW: Pleural effusion in rheumatoid arthritis: impaired transport of glucose. N Engl J Med 275: 1337, 1966.PubMedCrossRefGoogle Scholar
  37. 37.
    Jones SJ: An account of pleural effusions, pulmonary nodules and cavities in rheumatic disease. Br J Dis Chest 72: 39, 1978.PubMedCrossRefGoogle Scholar
  38. 38.
    Portner MM, Gracie WA: Rheumatoid lung disease with cavitary nodules, pneumothorax and eosinophilia. N Engl J Med 275: 697, 1966.PubMedCrossRefGoogle Scholar
  39. 39.
    Brannan HM, Good CA, Divertie MB, Baggenstoss AH: Pulmonary disease associated with rheumatoid arthritis. J Am Med Assoc 189: 914, 1964.CrossRefGoogle Scholar
  40. 40.
    Dixon AStJ, Ball J: Honeycomb lung and chronic rheumatoid arthritis: a case report. Ann Rheum Dis 16: 241, 1957.PubMedCrossRefGoogle Scholar
  41. 41.
    Stack BHR, Grant IWB: Rheumatoid interstitial lung disease. Br J Dis Chest 59: 202, 1965.PubMedCrossRefGoogle Scholar
  42. 42.
    Walker WC, Wright V: Diffuse interstitial pulmonary fibrosis and rheumatoid arthritis. Ann Rheum Dis 28: 252, 1969.PubMedCrossRefGoogle Scholar
  43. 43.
    Frank ST, Weg JG, Harkleroad LE, Fitch RF: Pulmonary dysfunction in rheumatoid disease. Chest 63: 27, 1973.PubMedCrossRefGoogle Scholar
  44. 44.
    Caplan A: Certain unusual radiographic appearances in the chest of coal miners suffering from RA. Thorax 8: 29, 1953.PubMedCrossRefGoogle Scholar
  45. 45.
    Caplan A, Cowen EDH, Gough J: Rheumatoid pneumoconiosis in a foundry worker. Thorax 13: 181, 1958.PubMedCrossRefGoogle Scholar
  46. 46.
    Chatgidakis CB, Theron C: Rheumatoid pneumoconiosis (Caplan’s syndrome): a discussion of the disease and a report of a case in a European Witwatersrand gold miner. Arch Environ Health 2: 397, 1961.PubMedGoogle Scholar
  47. 47.
    Hull S, Mathews JA: Pulmonary necrobiotic nodules as a presenting feature of rheumatoid arthritis. Ann Rheum Dis 41: 21, 1982.PubMedCrossRefGoogle Scholar
  48. 48.
    Walker WC: Pulmonary infections and rheumatoid arthritis. Q J Med 36: 239, 1967.PubMedGoogle Scholar
  49. 49.
    Catheart ES, Spodick DH: Rheumatoid heart disease: a study of the incidence and nature of cardiac lesions in rheumatoid arthritis. JAMA 266: 959, 1962.Google Scholar
  50. 50.
    Bongiglio T, Atwater EC: Heart disease in patients with seropositive rheumatoid arthritis: a controlled autopsy study and review. Arch Intern Med 124: 714, 1969.CrossRefGoogle Scholar
  51. 51.
    Cosh JA: Arthritis and the heart. Bristol Med Chir J 84: 145, 1969.PubMedGoogle Scholar
  52. 52.
    Comess KA, Fenster PE, Gall EP: Cardiac involvement in rheumatoid arthritis. Cardiovasc Res 3: 533, 1982.Google Scholar
  53. 53.
    Lie JT: Rheumatoid arthritis and heart disease. Primary Cardiol 40: 137, 1982.Google Scholar
  54. 54.
    Kirk J, Cosh J: The pericarditis of rheumatoid arthritis. Q J Med 38: 397, 1969.PubMedGoogle Scholar
  55. 55.
    Bacon PA, Gibson DG: Cardiac involvement in rheumatoid arthritis-an echocardiographic study. Ann Rheum Dis 31: 426, 1972.PubMedCrossRefGoogle Scholar
  56. 56.
    MacDonald WJ, Crawford MH, Klippel JH, Zvaifler NJ, O’Rourke RA: Echocardiographic assessment of cardiac structure and function in patients with rheumatoid arthritis. Am J Med 63: 890, 1977.PubMedCrossRefGoogle Scholar
  57. 57.
    Butman S, Espinoza LR, DelCarpio J, Osterland K: Rheumatoid pericarditis: rapid deterioration with evidence of local vasculitis. JAMA 238: 2394, 1977.PubMedCrossRefGoogle Scholar
  58. 58.
    Franco AE, Levine HO, Hall AP: Rheumatoid pericarditis: report of 17 cases diagnosed clinically. Ann Intern Med 77: 837, 1972.PubMedGoogle Scholar
  59. 59.
    Khan AH, Spodick DH: Rheumatoid heart disease. Semin Arthritis Rheum 1: 327, 1972.PubMedCrossRefGoogle Scholar
  60. 60.
    Sokoloff L: The heart in rheumatoid arthritis. Am Heart J 45: 635, 1953.PubMedCrossRefGoogle Scholar
  61. 61.
    Leibowitz WB: The heart in rheumatoid arthritis. Ann Intern Med 58: 102, 1963.Google Scholar
  62. 62.
    Harris M: Rheumatoid heart disease with complete heart block. J Clin Pathol 23: 623, 1970.PubMedCrossRefGoogle Scholar
  63. 63.
    Hoffman FG, Leight L: Complete atrioventricular block associated with rheumatoid disease. Am J Cardiol 16: 585, 1965.PubMedCrossRefGoogle Scholar
  64. 64.
    Roberts WC, Kehoe JA, Carpenter DF, Golden A: Cardiac valvular lesions in rheumatoid arthritis. Arch Intern Med 122: 141, 1968.PubMedCrossRefGoogle Scholar
  65. 65.
    Cruickshank B: Heart lesions in rheumatoid disease. J Pathol Bacteriol 76: 223, 1958.PubMedCrossRefGoogle Scholar
  66. 66.
    Goehrs HR, Baggenstoss AH, Slocumb CH: Cardiac lesions in rheumatoid arthritis. Arthritis Rheum 3: 298, 1960.PubMedCrossRefGoogle Scholar
  67. 67.
    Roberts WC, Dangel JC, Buklay BH: Non-rheumatic valvular cardiac disease: a clinicopathologic survey of 27 different conditions causing valvular dysfunction. Cardiovasc Clin 5: 333, 1973.PubMedGoogle Scholar
  68. 68.
    Reimer KA, Rodgers RF, Oyasu R: Rheumatoid arthritis with rheumatoid heart disease and granulomatous aortitis. JAMA 235: 2510, 1976.PubMedCrossRefGoogle Scholar
  69. 69.
    Bywaters EGL: The relation between heart and joint disease including “rheumatoid heart disease” and chronic postrheumatic arthritis (type Jaccoud). Br Heart J 12: 101, 1950.PubMedCrossRefGoogle Scholar
  70. 70.
    Karten I: Arteritis, myocardial infarction and rheumatoid arthritis. JAMA 210: 1717, 1969.PubMedCrossRefGoogle Scholar
  71. 71.
    Parrillo JE, Fauci AS: Necrotizing vasculitis, coronary angiitis and the cardiologist. Am Heart J 99: 547, 1980.PubMedCrossRefGoogle Scholar
  72. 72.
    Sweezy RL: Myocardial infarction due to rheumatoid arteritis. JAMA 199: 855, 1967.CrossRefGoogle Scholar
  73. 73.
    Chamberlain MA, Bruckner FE: Rheumatoid neuropathy: clinical and electrophysiological features. Ann Rheum Dis 29: 609, 1970.PubMedCrossRefGoogle Scholar
  74. 74.
    Weller RO, Bruckner FE, Chamberlain MA: Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 33: 592, 1970.PubMedCrossRefGoogle Scholar
  75. 75.
    Irby R, Adams RA, Toone EC: Peripheral neuritis associated with rheumatoid arthritis. Arthritis Rheum 1: 44, 1958.PubMedCrossRefGoogle Scholar
  76. 76.
    Pallis CA, Scott JT: Peripheral neuropathy in rheumatoid arthritis. Br Med J 1: 1141, 1965.PubMedCrossRefGoogle Scholar
  77. 77.
    Motulsky AG, Weinberg S, Saphir O, Rosenberg E: Lymph nodes in rheumatoid arthritis. Arch Intern Med 90: 660, 1952.CrossRefGoogle Scholar
  78. 78.
    Nosanshuk JS, Schnitzer B: Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. Cancer 24: 343, 1969.CrossRefGoogle Scholar
  79. 79.
    Robertson MDJ, Hart FD, White WF, Nuki G, Boardman PL: Rheumatoid lymphadenopathy. Ann Rheum Dis 27: 153, 1968.Google Scholar
  80. 80.
    Kassan SS, Hoover R, Kimberly RP: Increased incidence of malignancy in Sjögren’s syndrome. Arthritis Rheum 20: 123, 1977.Google Scholar
  81. 81.
    Whaley K, Webb J, McAvoy BA, Hughes GRC, Lee P, MacSween RNM, Buchanan WW: Sjögren’s syndrome. 2. Clinical associations and immunological phenomena. Q J Med 42: 513, 1973.PubMedGoogle Scholar
  82. 82.
    Felty AR: Chronic arthritis in the adult, associated with splenomegaly and leucopenia. Johns Hopkins Hosp Bull 35: 16, 1924.Google Scholar
  83. 83.
    Ruderman M, Miller LM, Pinals RS: Clinical and serologic observations on 27 patients with Felty’s syndrome. Arthritis Rheum 11: 377, 1968.PubMedCrossRefGoogle Scholar
  84. 84.
    Sienknecht CW, Urowitz MB, Pruzanski W, Stein HB: Felty’s syndrome. Clinical and serological analysis of 34 cases. Ann Rheum Dis 36: 500, 1977.PubMedCrossRefGoogle Scholar
  85. 85.
    Hurd ER, Andreis M, Ziff M: Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty’s syndrome. Clin Exp Immunol 28: 413, 1977.PubMedGoogle Scholar
  86. 86.
    Joyce RA, Boggs DR, Chervenick PA, Lalezari P: Neutrophil kinetics in Felty’s syndrome. Am J Med 69: 695, 1980.PubMedCrossRefGoogle Scholar
  87. 87.
    Howe GB, Fordham JN, Brown KA, Currey HLF: Polymorphonuclear cell function in rheumatoid arthritis and in Felty’s syndrome. Ann Rheum Dis 40: 370, 1981.PubMedCrossRefGoogle Scholar
  88. 88.
    Gupta RC, Laforce FM, Mills DM: Polymorphonuclear leukocyte inclusions and impaired bacterial killing in patients with Felty’s syndrome. J Lab Clin Med 88: 183, 1976.PubMedGoogle Scholar
  89. 89.
    Laszlo J, Jones R, Silberman HR, Banks PM: Splenectomy for Felty’s syndrome: clinicopathological study of 27 patients. Arch Intern Med 138: 597, 1978.PubMedCrossRefGoogle Scholar
  90. 90.
    Goldberg J, Pinals RS: Felty’s syndrome. Semin Arthritis Rheum 10: 52, 1980.PubMedCrossRefGoogle Scholar
  91. 91.
    Cohen AS: Amyloidosis associated with rheumatoid arthritis. Med Clin North Am 52: 643, 1968.PubMedGoogle Scholar
  92. 92.
    Husby G: Amyloidosis in rheumatoid arthritis. Ann Clin Res 7: 154, 1975.PubMedGoogle Scholar
  93. 93.
    Arapakis G, Tribe CR: Amyloidosis in rheumatoid arthritis investigated by means of rectal biopsy. Ann Rheum Dis 22: 256, 1963.PubMedCrossRefGoogle Scholar
  94. 94.
    Trieger N, Cohen AS, Calkins E: Gingival biopsy as a diagnostic aid in amyloid disease. Arch Oral Biol 1: 187, 1959.CrossRefGoogle Scholar
  95. 95.
    Falcek HM, Törnroth, Skrifvars B, Wegelius O: Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand 205: 651, 1979.CrossRefGoogle Scholar
  96. 96.
    Fernandes L, Sullivan S, McFarlane IG, Wojcicka BM, Warnes TW, Eddleston AL, Hamilton EB, Williams R. Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis. Ann Rheum Dis 38: 501, 1979.PubMedCrossRefGoogle Scholar
  97. 97.
    Weinblatt ME, Tesser JRP, Gilliam JH: The liver in rheumatic diseases. Semin Arthritis Rheum 11: 399, 1981.CrossRefGoogle Scholar
  98. 98.
    Mogadam M, Schuman B, Duncan H, Patton RB: Necrotizing colitis associated with rheumatoid arthritis. Gastroenterology 57: 168, 1969.PubMedGoogle Scholar
  99. 99.
    Pettersson T, Wegelius D, Skrifvars B: Gastrointestinal disturbances in patients with severe rheumatoid arthritis. Acta Med Scand 188: 139, 1970.CrossRefGoogle Scholar
  100. 100.
    Atwater EC, Morgan ES, Wieche DR, Jacox RF, Rochester NY: Peptic ulcer and rheumatoid arthritis: a prospective study. Arch Intern Med 115: 184, 1965.PubMedCrossRefGoogle Scholar
  101. 101.
    Brun C, Olsen TX, Rasshou F, Sorensen AW: Renal biopsy in rheumatoid arthritis. Nephron 2: 65, 1965.PubMedCrossRefGoogle Scholar
  102. 102.
    Healey LA, Bulger RJ: Abnormal renal function in rheumatoid arthritis. Arthritis Rheum 10: 283, 1967.Google Scholar
  103. 103.
    Pollack VE, Priani CL, Steck IE, et al.: The kidney in rheumatoid arthritis: studies by renal biopsy. Arthritis Rheum 5: 1, 1962.CrossRefGoogle Scholar
  104. 104.
    Lawson AAH, MacLean N: Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis 25: 441, 1966.PubMedGoogle Scholar
  105. 105.
    Samuels B, Lee JC, Engleman EP, Hooper J Jr: Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy. Medicine 57: 319, 1977.Google Scholar
  106. 106.
    O’Driscoll S, O’Driscoll M: Osteomalacia in rheumatoid arthritis. Ann Rheum Dis 39: 1, 1980.PubMedCrossRefGoogle Scholar
  107. 107.
    Williamson J: Incidence of eye disease in cases of connective tissue disease. Trans Ophthalmol Soc UK 94: 742, 1974.PubMedGoogle Scholar
  108. 108.
    Thompson M, Eadie S: Keratoconjunctivitis sicca and rheumatoid arthritis. Ann Rheum Dis 5: 21, 1956.CrossRefGoogle Scholar
  109. 109.
    Lackington MC, Charlin VC, Gormas BA: Keratoconjunctivitis sicca y artritis reumatoidea. Rev Med Chil 79: 133, 1951.Google Scholar
  110. 110.
    Lamberts DW: Dry eye and tear deficiency. Int Ophthalmol Clin 23 (1): 123, 1983.PubMedCrossRefGoogle Scholar
  111. 111.
    Ichikawa Y, Takaya M, Saitoh H: Characterization of sicca symptoms in patients with Sjögren’s syndrome, and report of six cases lacking subjective sicca features (“subclinical syndrome”). Exp Clin Med 6: 229, 1981.Google Scholar
  112. 112.
    von Grosz S: Aetiologie und Therapy der Keratoconjunctivitis sicca. Klin Monatsbl Augenheilk 97: 472, 1936.Google Scholar
  113. 113.
    Sjögren H: Zur Kenntnis der Keratoconjunctivitis sicca. (Keratitis filiformis bei Hypofunktion der Tränen drusen). Acta Ophthalmol Suppl 2: 1, 1933.Google Scholar
  114. 114.
    McGavin DDM, Williamson J, Forrester JV, Foulds WS, Buchanan WW, Dick WC, Lee P, MacSween RN, Whaley K: Episcleritis and scleritis: a study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol 60: 192, 1976.PubMedCrossRefGoogle Scholar
  115. 115.
    Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magun BE: Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 134: 3027, 1985.PubMedGoogle Scholar
  116. 116.
    Koletsky AJ, Harking MW, Handshumacker RE: Cyclophilin• distribution and properties in normal and neoplastic tissues. J Immunol 137: 1054, 1986.PubMedGoogle Scholar
  117. 117.
    Sullivan DA: Hormonal modulation of tear volume in the rat. Exp Eye Res 42: 131, 1986.PubMedCrossRefGoogle Scholar
  118. 118.
    Leuenberger PM, Miescher PA: Syndrome de Sjögren: Traitement par la ciclosporine: communication preliminaire. Klin Monatsbl Augenheilk 190: 290, 1987.CrossRefGoogle Scholar
  119. 119.
    Drosos AA, Skopouli FN, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM: Cyclosporine A in primary Sjögren’s syndrome: a double blind study. Ann Rheum Dis 45: 732, 1986.PubMedCrossRefGoogle Scholar
  120. 120.
    Kaswan RL, Salisbury MA, Ward DA: Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Arch Ophthalmol 107: 1210, 1989.PubMedCrossRefGoogle Scholar
  121. 121.
    Lyne AJ, Pitkeathley DA: Episcleritis and scleritis. Arch Ophthalmol 80: 171, 1968.PubMedCrossRefGoogle Scholar
  122. 122.
    Watson PG, Hayreh SS: Scleritis and episcleritis. Br J Ophthalmol 60: 163, 1976.PubMedCrossRefGoogle Scholar
  123. 123.
    Tuft SJ, Watson PG: Progression of scleral disease. Ophthalmology 98: 467, 1991.PubMedGoogle Scholar
  124. 124.
    Sevel D: Necrogranulomatous scleritis: clinical and histologic features. Am J Ophthalmol 64: 1125, 1967.PubMedGoogle Scholar
  125. 125.
    Jayson MIV, Jones DEP: Scleritis and rheumatoid arthritis. Ann Rheum Dis 30: 343, 1971.PubMedCrossRefGoogle Scholar
  126. 126.
    Kleiner RC, Raber IM, Passero FC: Scleritis, pericarditis, and aortic insufficiency in a patient with rheumatoid arthritis.Google Scholar
  127. 127.
    Sevel D: Rheumatoid nodule of the sclera (a type of necrogranulomatous scleritis). Trans Ophthalmol Soc UK 85: 357, 1965.PubMedGoogle Scholar
  128. 128.
    Jones P, Jayson MIV: Rheumatoid scleritis: a long-term follow up. Proc R Soc Med 66: 1161, 1973.PubMedGoogle Scholar
  129. 129.
    Foster CS, Forstot SL, Wilson LA: Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmology 91: 1253, 1984.PubMedGoogle Scholar
  130. 130.
    Smoleroff JW: Scleral disease in rheumatoid arthritis; report of three cases, in one of which both eyes were studied post mortem. Arch Ophthalmol 29: 98, 1943.CrossRefGoogle Scholar
  131. 131.
    Hurd ER, Snyder WB, Ziff M: Choroidal nodules and retinal detachments in rheumatoid arthritis. Am J Med 48: 273, 1970.PubMedCrossRefGoogle Scholar
  132. 132.
    Lachman SM, Hazleman BL, Watson PG: Scleritis and associated disease. Br Med J 1: 88, 1978.CrossRefGoogle Scholar
  133. 133.
    Brown SI, Grayson M: Marginal furrows: a characteristic corneal lesion of rheumatoid arthritis. Arch Ophthalmol 79: 563, 1968.PubMedCrossRefGoogle Scholar
  134. 134.
    Eiferman RA, Carothers DJ, Yankeelov JA: Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol 87: 703, 1979.PubMedGoogle Scholar
  135. 135.
    Jayson MIV, Easty DL: Ulceration of the cornea in rheumatoid arthritis. Ann Rheum Dis 36: 428, 1977.PubMedCrossRefGoogle Scholar
  136. 136.
    Scharf Y, Meyer E, Nahir M, Zonis S: Marginal mottling of cornea in rheumatoid arthritis. Ann Ophthalmol 16: 924, 1984.PubMedGoogle Scholar
  137. 137.
    Lyne AJ: “Contact lens” cornea in rheumatoid arthritis. Br J Ophthalmol 54:410, 1970.Google Scholar
  138. 138.
    Sainz de la Maza M, Foster CS: The diagnosis and treatment of peripheral ulcerative keratitis. Semin Ophthalmol 6 (3): 133, 1991.CrossRefGoogle Scholar
  139. 139.
    Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS: An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 9 (1): 66, 1990.PubMedCrossRefGoogle Scholar
  140. 140.
    Kimura SJ, Hogan MJ, O’Connor GR, EpsTein WV: Uveitis and joint diseases. Arch Ophthalmol 77: 309, 1967.PubMedCrossRefGoogle Scholar
  141. 141.
    Meyer E, Scharf J, Miller B, Zonis S, Nahis M: Fundus lesions in rheumatoid arthritis. Ann Ophthalmol 10: 1583, 1978.PubMedGoogle Scholar
  142. 142.
    Martin M, Scott D, Gilbert C, Dieppe PA, Easty DL: Retinal vasculitis in rheumatoid arthritis. Br J Ophthalmol 282: 1745, 1981.Google Scholar
  143. 143.
    Crompton J, Iyer P, Begg M: Vasculitis and ischemic optic neuropathy associated with rheumatoid arthritis. Aust J Ophthalmol 8: 219, 1980.PubMedCrossRefGoogle Scholar
  144. 144.
    Killian PJ, McClain B, Lawless OJ: Brown’s syndrome: an unusual manifestation of rheumatoid arthritis. Arthritis Rheum 20: 1080, 1977.PubMedCrossRefGoogle Scholar
  145. 145.
    Sandford-Smith JH: Intermittent superior oblique tendon sheath syndrome. Br J Ophthalmol 53: 412, 1969.PubMedCrossRefGoogle Scholar
  146. 146.
    Watson P, Fekete J, Deck J: Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci 4: 269, 1977.PubMedGoogle Scholar
  147. 147.
    Ramos M, Mandybur TI: Cerebral vasculitis in rheumatoid arthritis. Arch Neurol 32: 271, 1975.PubMedCrossRefGoogle Scholar
  148. 148.
    Victor DI, Green WR, Stark WJ, Walsh FB: A non-permanent tonic pupil in rheumatoid arthritis. Can J Neurol Sci 4: 209, 1977.PubMedGoogle Scholar
  149. 149.
    Edström G, Osterlind G: A case of nodular rheumatic episcleritis. Acta Ophthalmol 26: 1, 1948.Google Scholar
  150. 150.
    Mundy WL, Howard RY, Stillman PH, Bevans M: Cortisone therapy in case of rheumatoid nodules of the eye in chronic rheumatoid arthritis. Arch Ophthalmol 45: 531, 1951.CrossRefGoogle Scholar
  151. 151.
    Fienberg R, Colpoys FL Jr: The involution of rheumatoid nodules treated with cortisone and of non-treated rheumatoid nodules. Am J Pathol 27: 925, 1951.PubMedGoogle Scholar
  152. 152.
    Ferry AP: The histopathology of rheumatoid episcleral nodules: an extra-articular manifestation of rheumatoid arthritis. Arch Ophthalmol 82: 77, 1969.PubMedCrossRefGoogle Scholar
  153. 153.
    Leibowitz MA, Jakobiec FA, Donnenfeld ED, Stavr M: Bilateral epibulbar rheumatoid nodulosis. A new ocular entity. Ophthalmology 95: 1256, 1988.Google Scholar
  154. 154.
    Mesara BW, Brody GL, Oberman HA: “Pseudorheumatoid” subcutaneous nodules. Am J Clin Pathol 45: 684, 1966.PubMedGoogle Scholar
  155. 155.
    Rao NA, Font RL: Pseudorheumatoid nodules of the ocular anexa. Am J Ophthalmol 79: 471, 1975.PubMedGoogle Scholar
  156. 156.
    Ross MJ, Cohen KL, Peiffer RL Jr, Grimson BS: Episcleral and orbital pseudorheumatoid nodules. Arch Ophthalmol 101: 418, 1983.PubMedCrossRefGoogle Scholar
  157. 157.
    Rose HM, Ragan C, Pearce E, Lipman MO: Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 68: 1, 1948.PubMedGoogle Scholar
  158. 158.
    Waaler E: On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 17: 172, 1940.CrossRefGoogle Scholar
  159. 159.
    Tarkowski A, Czerkinsky C, Nilsson L-A: Simultaneous induction of rheumatoid factor-and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin Exp Immunol 61: 379, 1985.PubMedGoogle Scholar
  160. 160.
    Aho K, Palosuo T, Raunio V, Puska P, Aromaa A, Salonen JT: When does rheuma toid disease start? Arthritis Rheum 28: 485, 1985.PubMedCrossRefGoogle Scholar
  161. 161.
    Ball J, Lawrence JS: The relationship of rheumatoid serum factor to rheumatoid arthritis. Ann Rheum Dis 22: 311, 1963.PubMedCrossRefGoogle Scholar
  162. 162.
    Del Puente A, Knowler WC, Pettitt DJ, Bennett PH: The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 31: 1239, 1988.PubMedCrossRefGoogle Scholar
  163. 163.
    Bland JH, Brown EW: Seronegative and seropositive rheumatoid arthritis: clinical, radiological, and biochemical differences. Ann Intern Med 60: 88, 1964.PubMedGoogle Scholar
  164. 164.
    Kellgren JH, O’Brien WM: On the natural history of rheumatoid arthritis in relation to the sheep cell agglutination test (SCAT). Arthritis Rheum 5: 115, 1962.Google Scholar
  165. 165.
    Jacoby RK, Jayson MIV, Cosh JA: Onset, early stages and prognosis of rheumatoid ar thritis: a clinical study of 100 patients with 11 year follow-up. Br Med J 2: 96, 1973.PubMedCrossRefGoogle Scholar
  166. 166.
    Theofilopoulos AN, Burtonboy G, LoSpalluto JJ, Ziff M: IgM rheumatoid factor and low molecular weight IgM: an association with vasculitis. Arthritis Rheum 17: 272, 1974.PubMedCrossRefGoogle Scholar
  167. 167.
    Engstedt L, Strandberg O: Haematological data and clinical activity of the rheumatoid diseases. Acta Med Scand 180: 13, 1966.CrossRefGoogle Scholar
  168. 168.
    Samson D, Holliday D, Gumpel JM: Role of ineffective erythropoiesis in the anaemia of rheumatoid arthritis. Ann Rheum Dis 36: 181, 1977.PubMedCrossRefGoogle Scholar
  169. 169.
    Hutchinson RM, Davis P, Jayson MIV: Thrombocytosis in rheumatoid arthritis. Ann Rheum Dis 35: 138, 1976.PubMedCrossRefGoogle Scholar
  170. 170.
    Winchester RJ, Litwin SD, Koffler D, Kunkel HG: Observations on the eosinophilia of certain patients with rheumatoid arthritis. Arth ritis Rheum 14: 650, 1971.CrossRefGoogle Scholar
  171. 171.
    Panush RS, Franco AE, Schur PH: Rheumatoid arthritis associated with eosinophilia. Ann Intern Med 75: 199, 1971.PubMedGoogle Scholar
  172. 172.
    Fleming A, Crown JM, Corbett M: Prognostic value of early features in rheumatoid disease. Br Med J 1: 1243, 1976.PubMedCrossRefGoogle Scholar
  173. 173.
    Amos RS, Constable TJ, Crockson RA, Crockson AP, McConkery B: Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radio graphic changes. Br Med J 1: 195, 1977.PubMedCrossRefGoogle Scholar
  174. 174.
    Nusinow S, Arnold WJ: Prognostic value of Creactive protein (CRP) levels in rheumatoid arthritis. Clin Res 30: 474, 1982.Google Scholar
  175. 175.
    Roth SH: Remission: the goal of rheumatic disease therapy. J Rheumatol 9 (8): 120, 1982.Google Scholar
  176. 176.
    Ruddy S, Austen KF: Activation of the complement system in rheumatoid synovitis. Fed Proc 32: 134, 1973.PubMedGoogle Scholar
  177. 177.
    Jones VE, Jacoby RK, Wallington T, Holt P: Immune complexes in early arthritis. I. Detection of immune complexes before rheumatoid arthritis is definite. Clin Exp Immunol 44: 512, 1981.PubMedGoogle Scholar
  178. 178.
    Zubler RH, Nydegger UE, Perrin LH, Fehr K, McCormick J, Lambert PH, Miescher PA: Circulating and intraarticular immune complexes in patients with rheumatoid arthritis. J Clin Invest 57: 1308, 1976.PubMedCrossRefGoogle Scholar
  179. 179.
    Lessard J, Nunnery E, Cecere F, McDuffy S, Pope RM: Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors. J Rheumatol 10: 411, 1983.PubMedGoogle Scholar
  180. 180.
    Fessel WJ: SLE in the community: incidence, prevalence, outcome and first symptoms; the high prevalence in black women. Arch Intern Med 134: 1027, 1974.PubMedCrossRefGoogle Scholar
  181. 181.
    Siegel M, Lee SL: The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 3: 1, 1973.PubMedCrossRefGoogle Scholar
  182. 182.
    Arnett FC, Shulman LE: Studies in familial systemic lupus erythematosus. Medicine 55: 313, 1976.PubMedCrossRefGoogle Scholar
  183. 183.
    Winchester RJ, Nunez-Roldon A: Some genetic aspects of systemic lupus erythematosus. Arthritis Rheum 25: 833, 1982.PubMedCrossRefGoogle Scholar
  184. 184.
    Hess EV: Introduction to drug related lupus. Kroc Foundation Conference on Drug Induced Lupus. Arthritis Rheum 24: 979, 1981.CrossRefGoogle Scholar
  185. 185.
    Armas-Cruz R, Harnecker, J, Ducach G, Jalil J, Gonzales F: Clinical diagnosis of systemic lupus erythematosus. Am J Med 25: 409, 1958.PubMedCrossRefGoogle Scholar
  186. 186.
    Davis P, Atkins B, Jesse RG, Highes GRV: Criteria for classification of SLE. Br Med J 3: 88, 1973.PubMedCrossRefGoogle Scholar
  187. 187.
    Labowitz R, Schumacher HR: Articular manifestations of systemic lupus erythematosus. Ann Intern Med 74: 911, 1971.PubMedGoogle Scholar
  188. 188.
    Isbender DA, Snaith ML: Muscle disease in systemic lupus erythematosus: a study of its nature, frequency and cause. J Rheumatol 8: 917, 1981.Google Scholar
  189. 189.
    Gilliam JN, Sontheimer OO: Skin manifest tations of SLE. Clin Rheum Dis 8: 207, 1982.PubMedGoogle Scholar
  190. 190.
    Ropes MW: Systemic Lupus Erythematosus. Harvard University Press, Cambridge, 1976.Google Scholar
  191. 191.
    Ellis SG, Verity MA: Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 8: 212, 1979.PubMedCrossRefGoogle Scholar
  192. 192.
    Pirani CL, Pollack VE: Systemic lupus erythematosus glomerulonephritis. In Andres GA, McCluskey RT (Eds): Immunologically Mediated Renal Disease: Criteria for Diagnosis. Marcel Dekker, New York, 1978.Google Scholar
  193. 193.
    Chia GL, Mah EPK, Feng PH: Cardiovascular abnormalities in systemic lupus erythematosus. J Clin Ultrasound 9: 237, 1981.PubMedCrossRefGoogle Scholar
  194. 194.
    Bonfiglio TA, Botti RE, Hagstrom JWC: Coronary arteritis, occlusion and myocardial infarction due to lupus erythematosus. Am Heart J 83: 153, 1972.PubMedCrossRefGoogle Scholar
  195. 195.
    Homcy CJ, Liberthson RR, Fallon JT, Gross S, Miller LM: Ischemic heart disease in systemic lupus erythematosus: report of six cases. Am J Cardiol 49: 478, 1982.PubMedCrossRefGoogle Scholar
  196. 196.
    Libman E, Sacks B: A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 33: 701, 1924.CrossRefGoogle Scholar
  197. 197.
    Buckley BH, Roberts WC: The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 58: 243, 1975.CrossRefGoogle Scholar
  198. 198.
    Feinglass EJ, Arnett FC, Dorsch CA, Zizic RM, Stevens MC: Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum and relationship to other features of the disease. Medicine 55: 323, 1976.PubMedCrossRefGoogle Scholar
  199. 199.
    Klippel JH, Zwaifler NJ: Neuropsychiatric abnormalities in systemic lupus erythematosus. Clin Rheum Dis 1: 621, 1975.Google Scholar
  200. 200.
    Haupt HM, Moore GW, Hutchins GM: The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med 71: 791, 1981.PubMedCrossRefGoogle Scholar
  201. 201.
    Matthay RA, Schwartz MI, Petty TL, Stanford RE, Gupta RC, Sahn SA, Steigerwald JC: Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine 54: 397, 1974.CrossRefGoogle Scholar
  202. 202.
    Runyon BA, LaBrecque DR, Anuras S: The spectrum of liver disease in systemic lupus erythematosus: report of 33 hystologically proved cases and review of the literature. Am J Med 69: 187, 1980.PubMedCrossRefGoogle Scholar
  203. 203.
    Dillon AM, Stein HB, English RA: Splenic atrophy in SLE. Ann Intern Med 96: 40, 1982.PubMedGoogle Scholar
  204. 204.
    Foster CS. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology 87: 140, 1980.PubMedGoogle Scholar
  205. 205.
    Watson PG, Hazleman BL: The Sclera and Systemic Disorders. W.B. Saunders, Philadelphia, 1976, pp 206–305.Google Scholar
  206. 206.
    Cappaert WE, Purnell EW, Frank KE: Use of B-sector scan ultrasound in the diagnosis of benign choroidal folds. Am J Ophthalmol 84: 375, 1977.PubMedGoogle Scholar
  207. 207.
    Gold DH, Morris DA, Henkind P: Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 56: 800, 1972.PubMedCrossRefGoogle Scholar
  208. 208.
    Larson DL: Systemic Lupus Erythematosus. Little Brown, Boston, 1961.Google Scholar
  209. 209.
    Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH: Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 33: 291, 1954.PubMedCrossRefGoogle Scholar
  210. 210.
    Frith P, Burge SM, Millard PR, Wojnarowska F: External ocular findings in lupus erythematosus: a clinical and immunopathological study. Br J Ophthalmol 74: 163, 1990.PubMedCrossRefGoogle Scholar
  211. 211.
    Reeves JA: Keratopathy associated with systemic lupus erythematosus. Arch Ophthalmol 74: 159, 1965.PubMedCrossRefGoogle Scholar
  212. 212.
    Henkind P, Gold DH: Ocular manifestations of rheumatic disorders: natural and iatrogenic. Rheumatology 4: 13, 1973.PubMedGoogle Scholar
  213. 213.
    Halmay O, Ludwig K: Bilateral bandshaped deep keratitis and iridocyclitis in systemic lupus erythematosus. Br J Ophthalmol 48: 558, 1964.PubMedCrossRefGoogle Scholar
  214. 214.
    Spaeth GL: Corneal staining in systemic lupus erythematosus. N Engl J Med 276: 1168, 1967.PubMedCrossRefGoogle Scholar
  215. 215.
    Heaton JM: Sjögren’s syndrome and systemic lupus erythematosus. Br Med J 1: 466, 1959.PubMedCrossRefGoogle Scholar
  216. 216.
    Bencze G, Lakatos L: Relationship of systemic lupus erythematosus to rheumatoid arthritis, discoid lupus erythematosus, and Sjögren’s syndrome. Ann Rheum Dis 22: 273, 1963.PubMedCrossRefGoogle Scholar
  217. 217.
    Dubois EL: The clinical picture of systemic lupus erythematosus. In Dubois EL (Ed): Lupus Erythematosus. McGraw-Hill, New York, 1966, pp 129–276.Google Scholar
  218. 218.
    Steinberg AD, Talal N: The coexistence of Sjögren’s syndrome and systemic lupus erythematosus. Ann Intern Med 74: 55, 1971.PubMedGoogle Scholar
  219. 219.
    Brihaye-Van Geertruyden M, Danis P, Toussaint C: Fundus lesions with disseminated lupus. Arch Ophthalmol 51: 799, 1954.CrossRefGoogle Scholar
  220. 220.
    Maumenee AE: Retinal lesions in lupus erythematosus. Am J Ophthalmol 23: 971, 1940.Google Scholar
  221. 221.
    Clifton F, Greer CH: Ocular changes in acute systemic lupus erythematosus. Br J Ophthalmol 39: 1, 1955.PubMedCrossRefGoogle Scholar
  222. 222.
    Rothfield N: Clinical features of systemic lupus erythematosus. In Kelley WN, Harris ED, Ruddy S, Sledge CB (Eds): Textbook of Rheumatology. W.B. Saunders, Philadelphia, 1985, pp 1070–1097.Google Scholar
  223. 223.
    Regan CDJ, Foster CS: Retinal vascular diseases: clinical presentation and diagnosis. Int Ophthalmol Clin 26: 25, 1985.CrossRefGoogle Scholar
  224. 224.
    Silberberg DH, Laties AM: Increased intracranial pressure in disseminated lupus erythematosus. Arch Neurol 29: 88, 1973.PubMedCrossRefGoogle Scholar
  225. 225.
    Raptk L, Menard HA: Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 66: 1391, 1980.CrossRefGoogle Scholar
  226. 226.
    Weinstein A, Bordwell B, Stone B, Tibbetts C, Rothfield NF: Antibodies to native DNA and serum complement (C3) levels: applications to the diagnosis of systemic lupus erythematosus. Am J Med 74: 206, 1983.PubMedCrossRefGoogle Scholar
  227. 227.
    Arnett FC: Seronegative spondylarthropathies. Bull Rheum Dis 37 (1): 1, 1987.PubMedGoogle Scholar
  228. 228.
    Marks SH, Barnett M, Calin A: Ankylosing spondylitis in women and men: a case-control study. J Rheumatol 10: 624, 1983.PubMedGoogle Scholar
  229. 229.
    Woodrow JC: Genetic aspects of spondylarthropathies. Clin Rheum Dis 11: 1, 1985.PubMedGoogle Scholar
  230. 230.
    Brewerton DA, Caffrey M, Hart FD, James DCO, Nicholls A, Sturrock RD: Ankylosing spondylitis and HL-A 27. Lancet 1: 904, 1973.PubMedCrossRefGoogle Scholar
  231. 231.
    Van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27: 361, 1984.PubMedCrossRefGoogle Scholar
  232. 232.
    Hunter T, Dubo H: Spinal fractures complicating ankylosing spondylitis. Ann Intern Med 88: 546, 1978.PubMedGoogle Scholar
  233. 233.
    Khan MA: Ankylosing spondylitis. In Calin A (Ed): Spondyloarthropathies. Grune and Stratton, Orlando, FL, 1984, pp 69–117.Google Scholar
  234. 234.
    Bergfeldt L, Moller E: Complete heart block-another HLA-B27 associated disease manifestation. Tissue Antigens 21: 385, 1983.PubMedCrossRefGoogle Scholar
  235. 235.
    Bergfeldt L: HLA-B27 associated rheumatic diseases with severe cardiac bradyarrhythmias: clinical features and prevalence in 223 men with permanent pacemaker. Am J Med 75: 210, 1983.PubMedCrossRefGoogle Scholar
  236. 236.
    Khan MA, Kushner I: Ankylosing spondylitis and multiple sclerosis: a possible association. Arthritis Rheum 22: 784, 1979.PubMedCrossRefGoogle Scholar
  237. Mason RM, Murray RS, Oates JK, Prostatitis and ankylosing spondylitis. Rheum Phys Med 1:78, 1971.Google Scholar
  238. 238.
    Calin A: Renal glomerular function in ankylosing spondylitis. Scand J Rheumatol 4: 241, 1975.PubMedCrossRefGoogle Scholar
  239. 239.
    Pasternack A, Tornroth T, Martio J: Ultrastructural studies of renal arteriolar changes in ankylosing spondylitis. Acta Pathol Microbiol Scand Sect A, 79: 591, 1971.Google Scholar
  240. 240.
    Jayson MIV, Salmon PR, Harrison W: Amyloidosis in ankylosing spondylitis. Rheum Phys Med 1: 78, 1971.CrossRefGoogle Scholar
  241. 241.
    Jennette JC, Ferguson AL, Moore MA, Freeman DG: IgA nephropathy associated with seronegative spondylarthropathies. Arthritis Rheum 25: 144, 1982.PubMedCrossRefGoogle Scholar
  242. 242.
    Bluestone R: Ankylosing spondylitis. In McCarthy DJ (Ed): Arthritis and Allied Conditions, 10th ed. Lea and Febiger, Philadelphia, 1985, pp 819–840.Google Scholar
  243. 243.
    Hakin KN, Watson PG: Systemic associations of scleritis. Int Ophthalmol Clin 31 (3): 111, 1991.PubMedCrossRefGoogle Scholar
  244. 244.
    Rosenbaum JT, Theofilopoulos A, McDevitt HO, Pereira AB, Carson D, Calin A: Presence of circulating immune complexes in Reiter’s syndrome and ankylosing spondylitis. Clin Immun Pathol 18: 291, 1981.Google Scholar
  245. 245.
    Keat AC: Reiter’s syndrome and reactive arthritis in perspective. N Engl J Med 309: 1606, 1983.PubMedCrossRefGoogle Scholar
  246. 246.
    Moller G. Immunology of reactive arthritis and ankylosing spondylitis Immunol Rev 86: 1, 1985.Google Scholar
  247. 247.
    Reiter H: Ueber eine bisher unerkannte Spirochaeteninfektion (Spirochaetosis arthritica). Dtsch Med Wochenschr 42: 1435, 1916.Google Scholar
  248. 248.
    Aho K, Leirisalo-Repo M, Reop H: Reactive arthritis. In Panayi GS (Ed): Seronegative Spondyloarthropathies, Vol 11. W.B. Saunders, London, 1985, pp 25–40.Google Scholar
  249. 249.
    Winchester R, Bernstein DH, Fisher HD, Enlow R, Solomon G: The co-occurrence of Reiter’s syndrome and acquired immunodeficiency. Ann Intern Med 106: 19, 1987.PubMedGoogle Scholar
  250. 250.
    Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios A: Acquired immunodeficiency syndrome-associated psoriasis and Reiter’s syndrome. Arch Dermatol 123: 1622, 1987.PubMedCrossRefGoogle Scholar
  251. 251.
    Lin RY: Reiter’s syndrome and human immunodeficiency virus infection. Dermatologica 176: 39, 1988.PubMedCrossRefGoogle Scholar
  252. 252.
    Carr JL, Friedman M: Keratodermia blennorrhagicum, report of a case with autopsy. Am J Pathol 20: 709, 1944.PubMedGoogle Scholar
  253. 253.
    Calin A: Spondyloarthropathies. Grune and Stratton, Orlando, FL, 1984.Google Scholar
  254. 254.
    Buskila D, Langevitz P, Tenenbaum J, Glad-man DD: Malar rash in a patient with Reiter’s syndrome-a clue for the diagnosis of human immunodeficiency virus infection. J Rheumatol 17: 843, 1990.PubMedGoogle Scholar
  255. 255.
    Lee DA, Barker SM, Su WPD, Allen GL, Liesegang TJ, Ilstrup DM: The clinical diagnosis of Reiter’s syndrome. Ophthalmology 93: 350, 1986.PubMedGoogle Scholar
  256. 256.
    Ostler HB, Dawson CR, Schachter J, Engle-man EP: Reiter’s syndrome. Am J Ophthalmol 71: 986, 1971.PubMedGoogle Scholar
  257. 257.
    Weinberger HW, Ropes MW, Kulka JP, Bauer W: Reiter’s syndrome, clinical and pathological observations: a long-term study of 16 cases. Medicine 41: 35, 1962.PubMedCrossRefGoogle Scholar
  258. 258.
    Zewi M: Morbus Reiteri. Acta Ophthalmol 25: 47, 1947.CrossRefGoogle Scholar
  259. 259.
    Mattson R: Recurrent retinitis in Reiter’s disease. Acta Ophthalmol 33: 403, 1955.Google Scholar
  260. 260.
    Gerber LH, Espinoza LR: Psoriatic Arthritis. Grune and Stratton, Orlando, FL, 1985.Google Scholar
  261. 261.
    Suarez-Almazor ME, Russell AS: Sacroiliitis in psoriasis: relationship to peripheral arthritis and HLA-B27. J Rheumatol 17: 804, 1990.PubMedGoogle Scholar
  262. 262.
    Bennet RM: Psoriatic arthritis. In McCarthy DJ (Ed): Arthritis and Allied Conditions, 11th ed. Lea and Febiger, Philadelphia, 1989, pp 954–971.Google Scholar
  263. 263.
    Gladman DD, Stafford-Brady F, Chang C, Lewandowski K, Russell ML: Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 17: 809, 1990.PubMedGoogle Scholar
  264. 264.
    Leczinsky CG: The incidence of arthropathy in a ten-year series of psoriasis cases. Acta Derm Venereol 28: 483, 1948.PubMedGoogle Scholar
  265. 265.
    Little M, Harvie JN, Lester RS: Psoriatic arthritis in severe psoriasis. Can Med Assoc J 112: 317, 1975.PubMedGoogle Scholar
  266. Roberts MET, Wright V, Hill AGS: Psoriatic arthritis: a follow-up study. Ann Rheum Dis 35:206, 1976.Google Scholar
  267. 267.
    Lambert JR, Wright V: Eye inflammation in psoriatic arthritis. Ann Rheum Dis 35: 354, 1976.PubMedCrossRefGoogle Scholar
  268. 268.
    Bird HA, Wright V: Psoriatic arthritis. Clin Rheum Dis 9: 671, 1983.PubMedGoogle Scholar
  269. 269.
    Palumbo PJ, Ward LE, Sauer WG: Musculoskeletal manifestations of inflammatory bowel disease: ulcerative and granulomatous colitis and ulcerative proctitis. Mayo Clin Proc 48: 411, 1973.PubMedGoogle Scholar
  270. 270.
    Hopkins DJ, Horan E, Burton IL, Clamp SE, de Dombal FT, Goligher JC: Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol 58: 732, 1974.PubMedCrossRefGoogle Scholar
  271. 271.
    Wright R, Lumsden K, Luntz MH, Sevel D, Truelove SC: Abnormalities of the sacroiliac joints and uveitis in ulcerative colitis. Q J Med 34: 229, 1965.PubMedGoogle Scholar
  272. 272.
    Knox DL, Schachat AP, Mustonen E: Primary, secondary and coincidental ocular complications of Crohn’s disease. Ophthalmology 91: 163, 1984.PubMedGoogle Scholar
  273. 273.
    Billson FA, de Dombal FT, Watkinson G, Goligher JC: Ocular complications of ulcerative colitis. Gut 8: 102, 1967.PubMedCrossRefGoogle Scholar
  274. 274.
    Ernst BB, Lowder CY, Meisler D, Gutman FA: Posterior segment manifestations of inflammatory bowel disease. Ophthalmology 98: 1272, 1991.PubMedGoogle Scholar
  275. 275.
    Salmon JF, Wright JP, Murray ADN: Ocular inflammation in Crohn’s disease. Ophthalmology 98: 480, 1991.PubMedGoogle Scholar
  276. 276.
    Ellis PO, Gentry JH: Ocular complications of ulcerative colitis. Am J Ophthalmol 58: 779, 1964.PubMedGoogle Scholar
  277. 277.
    Petrelli EA, McKinley M, Troncale FJ: Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol 14: 356, 1982.PubMedGoogle Scholar
  278. 278.
    Jameson Evans P, Eustace P: Scleromalacia perforans associated with Crohn’s disease. Br J Ophthalmol 57: 330, 1973.CrossRefGoogle Scholar
  279. 279.
    Knox DL, Snip RC, Stark WJ: The keratopathy of Crohn’s disease. Am J Ophthalmol 90: 862, 1980.PubMedGoogle Scholar
  280. 280.
    Clark RL, Muhletaler CA, Margulies SI: Colitic arthritis: clinical and radiographic manifestations. Radiology 101: 585, 1971.PubMedGoogle Scholar
  281. 281.
    Jaksch-Wartenhorst R: Polychondropathia. Wien Arch Inn Med 6: 93, 1923.Google Scholar
  282. 282.
    White JW: Relapsing polychondritis. South Med J 78: 448, 1985.PubMedCrossRefGoogle Scholar
  283. 283.
    Isaak BL, Liesengang TJ, Michet CJ Jr: Ocular and systemic findings in relapsing polychondritis. Ophthalmology 93: 681, 1986.PubMedGoogle Scholar
  284. 284.
    Espinoza LR, Richman A, Bocanegra T, Pina I, Vasey FB, Rifkin SI, Germain BF: Immune complex-mediated renal involvement in relapsing polychondritis. Am J Med 71: 181, 1981.PubMedCrossRefGoogle Scholar
  285. 285.
    Sundaram MBM, Raiput AH: Nervous system complications of relapsing polychondritis. Neurology 33: 513, 1983.PubMedCrossRefGoogle Scholar
  286. 286.
    Margargal LE, Donoso LA, Goldberg RE, Gonder J, Brodsky I: Ocular manifestations of relapsing polychondritis. Retina 1: 96, 1981.CrossRefGoogle Scholar
  287. 287.
    McKay DAR, Watson PG, Lyne AJ: Relapsing polychondritis and eye disease. Br J Ophthalmol 58: 600, 1974.PubMedCrossRefGoogle Scholar
  288. 288.
    Matoba A, Plager S, Barger J, McCulley JP: Keratitis in relapsing polychondritis. Ann Ophthalmol 16: 367, 1984.PubMedGoogle Scholar
  289. 289.
    Anderson B Sr: Ocular lesions in relapsing polychondritis and other rheumatoid syndromes. Trans Am Acad Ophthalmol Otolaryngol 71: 227, 1967.PubMedGoogle Scholar
  290. 290.
    Michelson JB: Melting corneas with collapsing nose. Sury Ophthalmol 29: 148, 1984.CrossRefGoogle Scholar
  291. 291.
    Hoangh-Xuan T, Foster CS, Rice BA: Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology 97: 892, 1990.Google Scholar
  292. 292.
    McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM: Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55: 193, 1976.PubMedCrossRefGoogle Scholar
  293. 293.
    Damiani JM, Levine HL: Relapsing polychondritis-report of ten cases. Laryngoscope 89: 929, 1979.PubMedCrossRefGoogle Scholar
  294. 294.
    Kussmaul A, Maier K: Über eine bischer nicht beschreibene eigenthümliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii and rapid fortschreitender allgemeiner Müskellähmung einhergeht. Dtsch Arch Klin Med 1: 484, 1866.Google Scholar
  295. 295.
    Zeek PM: Periarteritis nodosa and other forms of necrotizing angiitis. N Engl J Med 18: 764, 1953.CrossRefGoogle Scholar
  296. 296.
    Lieb ES, Restivo C, Paulus HE Immunosuppressive and corticosteroid therapy for polyarteritis nodosa. Am J Med 67: 941, 1979.CrossRefGoogle Scholar
  297. 297.
    Kurland LT, Chuang TY, Hunder GG: The epidemiology of systemic arteritis. In Laurence RE, Shulman LE (Eds): Current Topics in Rheumatology: Epidemiology of the Rheumatic Diseases. Gower Medical Publishers, New York, 1984, pp 196–205.Google Scholar
  298. 298.
    Cupps TR, Fauci AS: The Vasculitides. W.B. Saunders, Philadelphia, 1981.Google Scholar
  299. 299.
    Cohen RD, Conn DL, Ilstrup DM: Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc 55: 146, 1980.PubMedGoogle Scholar
  300. 300.
    Goldstein I, Wexler D: The ocular pathology of periarteritis nodosa. Arch Ophthalmol 2: 288, 1929.CrossRefGoogle Scholar
  301. 301.
    Friedenwald JS, Rones B: Ocular lesions in septicemia. Arch Ophthalmol 5: 175, 1931.CrossRefGoogle Scholar
  302. 302.
    Gaynon IE, Asbury MK: Ocular findings in a case of periarteritis nodosa. Am J Ophthalmol 23: 1072, 1943.Google Scholar
  303. 303.
    Goldsmith J: Periarteritis nodosa with involvement of the choroidal and retinal arteries. Am J Ophthalmol 29: 435, 1946.PubMedGoogle Scholar
  304. 304.
    Goar EL, Smith LS: Polyarteritis nodosa of the eye. Am J Ophthalmol 35: 1619, 1952.PubMedGoogle Scholar
  305. 305.
    Sheehan B, Harriman DG, Bradshaw JP: Polyarteritis nodosa with ophthalmic and neurological complications. Arch Ophthalmol 60: 537, 1958.CrossRefGoogle Scholar
  306. 306.
    King RT: Ocular involvement in a case of periarteritis nodosa. Trans Ophthalmol Soc UK 55: 246, 1935.Google Scholar
  307. 307.
    Ford RG, Siekert RG: Central nervous system manifestations of periarteritis nodosa. Neurology 15: 114, 1965.PubMedCrossRefGoogle Scholar
  308. 308.
    Kimbrell OC Jr, Wheliss JA: Polyarteritis nodosa complicated by bilateral optic neuropathy. JAMA 201: 61, 1967.CrossRefGoogle Scholar
  309. 309.
    Van Wien S, Merz EH: Exophthalmos secondary to periarteritis nodosa. Am J Ophthalmol 56: 204, 1963.Google Scholar
  310. 310.
    Purcell JJ Jr, Birkenkamp R, Tsai CC: Conjunctival lesions in periarteritis nodosa, a clinical and immunopathologic study. Arch Ophthalmol 102: 736, 1984.PubMedCrossRefGoogle Scholar
  311. 311.
    Harbert F, McPherson SD: Scleral necrosis in periarteritis nodosa. Am J Ophthalmol 30: 727, 1947.PubMedGoogle Scholar
  312. 312.
    Wise GN: Ocular periarteritis nodosa. AMA Arch Ophthalmol 48: 1, 1952.PubMedCrossRefGoogle Scholar
  313. 313.
    Cogan DG: Corneoscleral lesions in periarteritis nodosa and Wegener’s granulomatosis. Trans Am Acad Ophthalmol 53: 321, 1955.Google Scholar
  314. 314.
    Moore JG, Sevel D: Corneoscleral ulceration in periarteritis nodosa. Br J Ophthalmol 50: 651, 1966.PubMedCrossRefGoogle Scholar
  315. 315.
    Longstreth PL, Lorobkin M, Palubinskas AJ: Renal microaneurysms in a patient with systemic lupus erythematosus. Radiology 113: 65, 1974.PubMedGoogle Scholar
  316. 316.
    McKusick VA: Buerger’s disease: a distinct clinical and pathologic entity. JAMA 181: 93, 1962.CrossRefGoogle Scholar
  317. 317.
    Diaz-Perez JL, Winkelmann RK: Cutaneous periarteritis nodosa. Arch Dermatol 110: 407, 1974.PubMedCrossRefGoogle Scholar
  318. 318.
    Sack M, Cassidy JT, Bole GG: Prognostic factors in polyarteritis. J Rheumatol 2: 411, 1975.PubMedGoogle Scholar
  319. 319.
    Dyck PJ, Conn DL, Okazaki H: Necrotizing angiopathic neuropathy: three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc 47: 461, 1972.PubMedGoogle Scholar
  320. 320.
    Churg J, Strauss L: Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27: 277, 1951.PubMedGoogle Scholar
  321. 321.
    Chumbley LC, Harrison EG Jr, Deremee RA: Allergic granulomatosis and angiitis (Churg Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 52: 477, 1977.PubMedGoogle Scholar
  322. 322.
    Lanham JG, Elkon KB, Pusey CD, Hughes GR: Systemic vasculitis with asthma and eosinophilia: a clinical approach to the ChurgStrauss syndrome. Medicine (Baltimore) 63: 65, 1984.Google Scholar
  323. 323.
    Nissim F, Von der Valde J, Czernobilsky B: A limited form of Churg—Strauss syndrome. Arch Pathol Lab Med 106: 305, 1982.PubMedGoogle Scholar
  324. 324.
    Cury D, Breakey AS, Payne BF: Allergic granulomatous angiitis associated with uveoscleritis and papilledema. Arch Ophthalmol 55: 261, 1950.CrossRefGoogle Scholar
  325. 325.
    Dicken CH, Winkelmann RK: The ChurgStrauss granuloma: cutaneous, necrotizing, palisading granuloma in vasculitis syndromes. Arch Pathol Lab Med 102: 576, 1978.PubMedGoogle Scholar
  326. 326.
    Strauss L, Churg J, Zak FG: Cutaneous lesions of allergic granulomatosis. A histopathologic study. J Invest Dermatol 17: 349, 1951.PubMedGoogle Scholar
  327. 327.
    Crotty CP, Deremee RA, Winkelmann RK: Cutaneous clinicopathologic correlation of allergic granulomatosis. J Am Acad Dermatol 5: 571, 1981.PubMedCrossRefGoogle Scholar
  328. 328.
    Wegener F: Über generalisierte, septische Gefässerkrankungen. Verh Dtsch Ges Pathol 29: 202, 1936.Google Scholar
  329. 329.
    Wegener F: Über eine eigenartige rhinogene Granulomatose mit besonderer Beteilingung des Arteriensystems und der Nieren. Beitr Pathol Anat Allg Pathol 102: 36, 1939.Google Scholar
  330. 330.
    Godman GC, Churg J: Wegener’s granulomatosis: pathology and review of the literature. Arch Pathol 58: 533, 1954.Google Scholar
  331. 331.
    Walton EW: Giant cell granuloma of the respiratory tract (Wegener’s granulomatosis). Br Med J 2: 265, 1958.PubMedCrossRefGoogle Scholar
  332. 332.
    Carrington CB, Leibow AA. Limited forms of angiitis and granulomatosis of Wegener’s type. Am J Med 41: 497, 1966.PubMedCrossRefGoogle Scholar
  333. 333.
    Gross WL: Wegener’s granulomatosis. New aspects of the disease course, immunodiagnostic procedures, and stage-adapted treatment. Sarcoidosis 6: 15, 1989.PubMedGoogle Scholar
  334. 334.
    Coutu RE, Klein M, Lessell S, Friedman E, Snider GL. Limited form of Wegener granulomatosis. Eye involvement as a major sign. JAMA 233: 868, 1975.PubMedCrossRefGoogle Scholar
  335. 335.
    Spalton DJ, Graham EM, Page NGR, Sanders MD: Ocular changes in limited forms of Wegener’s granulomatosis. Br J Ophthalmol 65: 553, 1981.PubMedCrossRefGoogle Scholar
  336. 336.
    McDonald TJ, DeRemee RA: Wegener’s granulomatosis. Laryngoscope 93: 220, 1983.PubMedCrossRefGoogle Scholar
  337. 337.
    DeRemee RA, McDonald TJ, Harrison EG Jr, Coles DT: Wegener’s granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc 51: 777, 1976.PubMedGoogle Scholar
  338. 338.
    Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients over 21 years. Ann Intern Med 98: 76, 1983.PubMedGoogle Scholar
  339. 339.
    Niffenegger JH, Jakobiec FA, Raizman MB, Foster CS: Pathologic diagnosis of very limited (ocular or orbital) Wegener’s granulomatosis (in press).Google Scholar
  340. 340.
    Hall SL, Miller LC, Duggan E, Mauer SM, Beatty EC, Hellerstein S: Wegener’s granulomatosis in pediatric patients. J Pediatr 106: 739, 1985.PubMedCrossRefGoogle Scholar
  341. 341.
    Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL: Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener’s granulomatosis. Ann Intern Med 111: 28, 1989.PubMedGoogle Scholar
  342. 342.
    Pinching AJ, Lockwood CM, Pussell BA, Rees A, Swaney P, Evans D, Bowley N, Peters D: Wegener’s granulomatosis: observations on 18 patients with severe renal disease. Q J Med 52: 435, 1983.PubMedGoogle Scholar
  343. 343.
    Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA: Ocular complications of Wegener’s granulomatosis. Ophthalmology 90: 279, 1983.PubMedGoogle Scholar
  344. 344.
    Haynes BF, Fishman ML, Fauci AS, Wolff SM: The ocular manifestations of Wegener’s granulomatosis. Fifteen years experience and review of the literature. Am J Med 63: 131, 1977.PubMedCrossRefGoogle Scholar
  345. 345.
    Straatsma BR: Ocular manifestations of Wegener’s granulomatosis. Am J Ophthalmol 44: 789, 1957.PubMedGoogle Scholar
  346. 346.
    Kinyoun JL, Kalina RE, Klein ML: Choroidal involvement in systemic necrotizing vasculitis. Arch Ophthalmol 105: 939, 1987.PubMedCrossRefGoogle Scholar
  347. 347.
    Schmidt R, Koderisch J, Krastel H, Zeier M, Andrassy K: Sicca syndrome in patients with Wegener’s granulomatosis. Lancet 1: 904, 1989.PubMedCrossRefGoogle Scholar
  348. 348.
    Leveille AS, Morse PH: Combined detachments in Wegener’s granulomatosis. Br J Ophthalmol 65: 564, 1981.PubMedCrossRefGoogle Scholar
  349. 349.
    Brubacker R, Font RL, Shepherd EM: Granulomatous sclerouveitis. Regression of ocular lesions with cyclophosphamide and prednisone. Arch Ophthalmol 86: 517, 1971.CrossRefGoogle Scholar
  350. 350.
    Sacks RD, Stock EL, Crawford SE, Greenwald MJ, O’Grady RB: Scleritis and Wegener’s granulomatosis in children. Am J Ophthalmol 111: 430, 1991.PubMedGoogle Scholar
  351. 351.
    Kalina PH, Garrity JA, Herman DC, DeRemee RA, Specks U: Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudo-tumor. Mayo Clin Proc 65: 1110, 1990.PubMedCrossRefGoogle Scholar
  352. 352.
    Charles SJ, Meyer PAR, Watson PG: Diagnosis and management of systemic Wegener’s granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol 75: 201, 1991.PubMedCrossRefGoogle Scholar
  353. 353.
    van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes; tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1: 425, 1985.PubMedCrossRefGoogle Scholar
  354. 354.
    Ludemann G, Gross WL: Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener’s granulomatosis. Clin Exp Immunol 69: 350, 1987.PubMedGoogle Scholar
  355. 355.
    Savage CS, Winearls CG, Jones S, Marshall PD, Lockwood CM: Prospective study of radio-immunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1: 1389, 1987.PubMedCrossRefGoogle Scholar
  356. 356.
    Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651, 1988.PubMedCrossRefGoogle Scholar
  357. 357.
    Niles JL, McCluskey RT, Ahmad MF, Arnaout MA: Wegener’s granulomatosis auto-antigen is a novel neutrophil serine protease. Blood 74: 1888, 1989.PubMedGoogle Scholar
  358. 358.
    Jennette JC, Wilkman AS, Falk RJ: Antineutrophil cytoplasmic autoantibody- associated glomerulonephritis and vasculitis. Am J Pathol 135: 921, 1989.PubMedGoogle Scholar
  359. 359.
    Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, Koolen MI, Hené RJ, The TH, van der Hem GK, von der Borne AEGKr, Kallenberg CGM: Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 33: 1264, 1990.PubMedCrossRefGoogle Scholar
  360. 360.
    Cohen Tervaert JW, Elema JD, Kallenberg CGM: Clinical and histopathological association of 29kD-ANCA and MPO-ANCA. APMIS 98 (Suppl 19): 35, 1990.CrossRefGoogle Scholar
  361. 361.
    Pulido JS, Goeken JA, Nerad JA, Sobol WM, Folberg R: Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodies. Arch Ophthalmol 108: 845, 1990.PubMedCrossRefGoogle Scholar
  362. 362.
    Soukiasian SH, Foster CS, Niles JL, Raizman MB: Diagnostic value of anti-neutrophil cytoplasmic antibodies (ANCA) in scleritis associated with Wegener’s granulomatosis. Ophthalmology 99 (1): 125, 1992.PubMedGoogle Scholar
  363. 363.
    Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ: The American College of Rheumatology 1990 criteria for the classification of WG. Arthritis Rheum 33: 1101, 1990.PubMedCrossRefGoogle Scholar
  364. 364.
    Feigenbaum A: Description of Behçet’s syndrome in the hippocratic third book of endemic diseases. Br J Ophthalmol 40: 355, 1956.PubMedCrossRefGoogle Scholar
  365. 365.
    Behçet H: Ueber rezidivieerende, aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge and an den Genitalien. Dermatol Wochenschr 105: 1152, 1937.Google Scholar
  366. Yamamoto S, Toyokawa H, Matsubara J.: A nation-wide survey of Behçet disease in Japan. 1. Epidemiological survey. Jpn J Ophthalmol 18:282, 1974.Google Scholar
  367. 367.
    Foster CS, Baer JC, Raizman MB: Therapeutic responses to systemic immunosuppressive chemotherapy agents in patients with Behçet’s syndrome affecting the eyes. Proc. Fifth International Congress on Behçet’s Disease, Rochester, MN, 1989.Google Scholar
  368. 368.
    Atmaca LS: Fundus changes associated with Behçet’s disease. Graefe’s Arch Clin Exp Ophthalmol 227: 340, 1989.PubMedCrossRefGoogle Scholar
  369. 369.
    BenEzra D, Cohen E: Treatment and visual prognosis in Behçet’s disease. Br J Ophthalmol 70: 589, 1986.PubMedCrossRefGoogle Scholar
  370. 370.
    Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K: Behçet’s disease in Japan: ophthalmological aspects. Trans Am Ophthalmol Soc 77: 225, 1979.PubMedGoogle Scholar
  371. 371.
    Colvard DM, Robertson DM, O’Duffy JD: The ocular manifestations of Behçet’s disease. Arch Ophthalmol 95: 1813, 1977.PubMedCrossRefGoogle Scholar
  372. 372.
    Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, Serdaroglu S, Ersani M, Ulku BY, Muftuoglu AU: Influence of age on onset and patients’ sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 43: 783, 1984.PubMedCrossRefGoogle Scholar
  373. 373.
    Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M: Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol 100: 1455, 1982.PubMedCrossRefGoogle Scholar
  374. 374.
    Baricordi OR, Sensi A, Pivetti-Pezzi P, Perrone S, Balboni A, Catarinelli G, Filippl F, Melchiouri R, Moncada A, Mattiuz PL: Behçet’s disease associated with HLA-B51 and DRw52 antigens in Italians. Hum Immunol 17: 297, 1986.PubMedCrossRefGoogle Scholar
  375. 375.
    Yazici H, Chamberlain MA, Schreuder I, D’Amaro J, Muftuoglu M: HLA antigens in Behçet’s disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 39: 344, 1980.PubMedCrossRefGoogle Scholar
  376. 376.
    O’Duffy JD, Taswell HF, Elvebeck LR: HL-A antigens in Behçet’s disease. J Rheumatol 3: 1, 1976.PubMedGoogle Scholar
  377. 377.
    Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WS: The pathergy test and Behçet’s syndrome in Britain. Ann Rheum Dis 43: 70, 1984.PubMedCrossRefGoogle Scholar
  378. 378.
    James DG, Spiteri MA: Behçet’s disease. Ophthalmology 89: 1279, 1982.PubMedGoogle Scholar
  379. 379.
    O’Duffy JD: Suggested criteria for the diagnosis of Behçet’s disease. J Rheumatol l(Suppl 1 ): 18, 1974.Google Scholar
  380. 380.
    Wechsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N, Kansu E, Yazici H, Barnes CG, Chamberlain MA, James DG, Lehner T, O’Duffy JD: (International Study Group for Behçet’s disease): Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078, 1990.Google Scholar
  381. 381.
    Wilkinson IMS, Russell RWR: Arteries of the head and neck in giant cell arteritis. Arch Neurol 27: 378, 1972.PubMedCrossRefGoogle Scholar
  382. 382.
    Klein RG, Hunder GG, Stanson AW, Sheps SG: Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 83: 806, 1975.PubMedGoogle Scholar
  383. Hunder GG, Bloch DA, Michel BA, Steuens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt, RY, Lie JT, et al.: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:8, 1990.Google Scholar
  384. 384.
    Bengtsson BA, Malmvall BE: The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Arthritis Rheum 24: 899, 1981.PubMedCrossRefGoogle Scholar
  385. 385.
    Friedman G, Friedman B, Benbassat J: Epidemiology of temporal arteritis in Israel. Isr J Med Sci 18: 241, 1982.PubMedGoogle Scholar
  386. 386.
    Machado EBV, Michet C, Ballard DJ, Hunder GG, Beard CM, Chu CP, O’Fallon WM: Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950–1985. Athritis Rheum 31: 745, 1988.CrossRefGoogle Scholar
  387. 387.
    Hazleman B, Goldstone A, Voak D: Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8. Br Med J 2: 989, 1977.PubMedCrossRefGoogle Scholar
  388. 388.
    Barrier J, Bignon JD, Soulillou JP, Grollean J: Increase prevalence of HLA-DR4 in giant-cell arteritis [Letter]. N Engl J Med 305: 104, 1981.PubMedCrossRefGoogle Scholar
  389. 389.
    Malmvall B, Bentsson B, Rydberg L: HLA antigens in patients with giant cell arteritis, compared with two control groups of different ages. Scand J Rheumatol 9: 65, 1980.PubMedCrossRefGoogle Scholar
  390. 390.
    Hunder GG, Taswell HF, Pineda AA, Elveback LR: HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica. J Rheumatol 4: 321, 1977.PubMedGoogle Scholar
  391. 391.
    Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR: Temporal arteritis. A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 89: 162, 1978.Google Scholar
  392. 392.
    Whitfield AGW, Bateman M, Trevor-Cooke W: Temporal arteritis. Br J Ophthalmol 47: 555, 1963.PubMedCrossRefGoogle Scholar
  393. 393.
    Hunder GG: Giant cell (temporal) arteritis. Rheum Dis Clin N Am 16: 399, 1990.Google Scholar
  394. 394.
    Caselli RJ, Hunder GG, Whisnant JP: Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 38: 352, 1988.PubMedCrossRefGoogle Scholar
  395. 395.
    Reich KA, Giansiracusa DF, Strongwater SL: Neurologic manifestations of giant cell arteritis. Am J Med 89: 67, 1990.PubMedCrossRefGoogle Scholar
  396. 396.
    Cohen MD, Ginsburg WW: Polymyalgia rheumatica. Rheum Dis Clin N Am 16: 325, 1990.Google Scholar
  397. 397.
    Hunder GG, Allen GL: Giant cell arteritis: a review. Bull Rheum Dis 29: 980, 1978–1979.Google Scholar
  398. 398.
    Chuang T, Hunder GG, Ilstrup DM, Kurland LT: Polymyalgia rheumatica. A 10-year epidemiological and clinical study. Ann Intern Med 97: 672, 1982.PubMedGoogle Scholar
  399. 399.
    Rynes RI, Mika P, Bartholomew LE: Development of giant cell (temporal) arteritis in a patient “adequately” treated for polymyalgia rheumatica. Ann Rheum Dis 36: 88, 1977.PubMedCrossRefGoogle Scholar
  400. 400.
    Birkhead NC, Wagener HP, Shick RM: Treatment of temporal arteritis with adrenal corticosteroids: results in 55 cases in which the lesion was proved at biopsy. JAMA 163: 821, 1975.CrossRefGoogle Scholar
  401. 401.
    Hollenhorst RW, Brown JR, Wagener HP, Schick RM: Neurologic aspects of temporal arteritis. Neurology 10: 490, 1960.PubMedCrossRefGoogle Scholar
  402. 402.
    Graham E, Holland A, Avery A, Russell RW: Prognosis in giant-cell arteritis. Br Med J 282: 269, 1981.CrossRefGoogle Scholar
  403. 403.
    Hayreh HH: Anterior ischemic optic neuropathy. Differentiation of arteritis from nonarteritic type and its management. Eye 4: 25, 1990.PubMedCrossRefGoogle Scholar
  404. 404.
    Daiker B, Keller HH: Riesenallarteriitis mit endookulärer Ausbreitung and Hypotonia bulbi dolorosa. Klin Monatsbl Augenheilk 158: 358, 1971.Google Scholar
  405. 405.
    Wong RL, Korn JH: Temporal arteritis without an elevated erythrocyte sedimentation rate. Am J Med 80: 959, 1986.PubMedCrossRefGoogle Scholar
  406. 406.
    Andersson R, Malmvall B, Bengtsson B: Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand 220: 365, 1986.PubMedCrossRefGoogle Scholar
  407. 407.
    Kyle V, Cawston TE, Hazleman BL: Ery throcyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheu matica/giant cell arteritis on presentation and during followup. Ann Rheum Dis 48: 667, 1989.PubMedCrossRefGoogle Scholar
  408. 408.
    Desmet GD, Knockaert DC, Bobbaers HJ: Temporal arteritis: the silent presentation and delay in diagnosis. J Intern Med 227: 237, 1990.PubMedCrossRefGoogle Scholar
  409. 409.
    Dasgupta B, Duke O, Timms AM, Pitzalis C, Panayi GS: Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 48: 307, 1989.PubMedCrossRefGoogle Scholar
  410. 410.
    Hall S, Hunder GG: Is temporal artery biopsy prudent? Mayo Clin Proc 59: 793, 1984.PubMedCrossRefGoogle Scholar
  411. 411.
    Albert DM, Ruchman MC, Keltner JL: Skip areas in temporal arteritis. Arch Ophthalmol 94: 2072, 1979.CrossRefGoogle Scholar
  412. 412.
    Allison MC, Gallagher PJ: Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 43: 416, 1984.PubMedCrossRefGoogle Scholar
  413. 413.
    Hedges TR, Geiger GL, Albert DM: The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 101: 1251, 1983.PubMedCrossRefGoogle Scholar
  414. 414.
    Hall S, Persellin S, Lie JT, O’Brien PC, Kurland LT, Hunder GG: The therapeutic impact of temporal artery biopsy. Lancet 2: 1217, 1983.PubMedCrossRefGoogle Scholar
  415. 415.
    Cogan DG: Syndrome of nonsyphilitic interstitial keratitis with vestibuloauditory symptoms. Arch Ophthalmol 33: 144, 1945.CrossRefGoogle Scholar
  416. 416.
    Cogan DG: Nonsyphilitic keratitis and vestibuloauditory symptoms: four additional cases. Arch Ophthalmol 42: 42, 1949.CrossRefGoogle Scholar
  417. 417.
    Cobo LM, Haynes BF: Early corneal findings in Cogan’s syndrome. Ophthalmology 91: 903, 1980.Google Scholar
  418. 418.
    Norton EW, Cogan DG: Syndrome of nonsyphilitic interstitial keratitis and vestibulo auditory symptoms. Arch Ophthalmol 61: 695, 1959.CrossRefGoogle Scholar
  419. 419.
    Roberts J: Cogan’s syndrome. Med J Aust 1: 186, 1965.PubMedGoogle Scholar
  420. 420.
    Cheson BD, Bluming AZ, Alroy J: Cogan’s syndrome: a systemic vasculitis. Am J Med 60: 549, 1976.PubMedCrossRefGoogle Scholar
  421. 421.
    Cogan DG, Dickerson GR: Nonsyphilitic interstitial keratitis with vestibuloauditory syndrome: a case with fatal aortitis. Arch Ophthalmol 71: 172, 1964.PubMedCrossRefGoogle Scholar
  422. 422.
    Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS: Cogan’s syndrome: studies in thirteen patients, long-term followup, and a review of the literature. Medicine 59: 426, 1980.PubMedCrossRefGoogle Scholar
  423. 423.
    Eisenstein B, Taubenhaus M: Nonsyphilitic interstitial keratitis and bilateral deafness (Cogan’s syndrome) associated with cardiovascular disease. N Engl J Med 258: 1074, 1958.PubMedCrossRefGoogle Scholar
  424. 424.
    Fisher ER, Hellstrom HR: Cogan’s syndrome and systemic vascular disease. Arch Pathol 72: 572, 1961.PubMedGoogle Scholar
  425. 425.
    Gelfand ML, Kantor T, Gorstein F: Cogan’s syndrome with cardiovascular involvement; aortic insufficiency. Bull NY Acad Med 48: 647, 1972.Google Scholar
  426. 426.
    Haynes BF, Pikus A, Kaiser-Kupfer MI, Fauci AS: Successful treatment of sudden hearing loss in Cogan’s syndrome with corticosteroids. Arthritis Rheum 24: 501, 1981.PubMedCrossRefGoogle Scholar
  427. 427.
    Bennet FM: Bilateral recurrent episcleritis associated with posterior corneal changes, vestibulo-auditory symptoms and rheumatoid arthritis. Am J Ophthalmol 55: 815, 1963.Google Scholar
  428. 428.
    Watson PG: Management of scleral disease. Trans Ophthalmol Soc UK 86: 151, 1966.PubMedGoogle Scholar
  429. 429.
    Gilbert WS, Talbot FJ: Cogan’s syndrome. Signs of periarteritis nodosa and cerebral venous sinus thrombosis. Arch Ophthalmol 82: 633, 1969.PubMedCrossRefGoogle Scholar
  430. 430.
    Holt-Wilson AD, Watson PG: Nonsyphilitic deep interstitial keratitis associated with scleritis. Trans Ophthalmol Soc UK 94: 52, 1974.Google Scholar
  431. 431.
    Hedges TR, Taylor GW: Uveal and vestibuloauditory disease with sarcoid. Arch Ophthalmol 48: 88, 1952.CrossRefGoogle Scholar
  432. 432.
    McGavin DDM, McNeill J: Scleritis and perceptive deafness: case report. Ann Ophthalmol 48: 1287, 1979.Google Scholar
  433. 433.
    Coca AF, Cooke RA: On the classification of the phenomena of hypersensitiveness. J Immunol 8: 163, 1923.Google Scholar
  434. 434.
    Duke-Elder S, Leigh AG: Diseases of the outer eye. Cornea and sclera. In Duke-Elder S (Ed): System of Ophthalmology, Vol 8, Part 2. C.V. Mosby, St. Louis, 1965, p 1034.Google Scholar
  435. 435.
    Braude LS, Chandler JW: Atopic corneal disease. Int Ophthalmol Clin 24 (2): 145, 1984.PubMedGoogle Scholar
  436. 436.
    Buckley RJ: Atopic disease of the corneal. In Cavanagh HD (Ed): The Cornea: Transactions of the World Congress of the Cornea III. Raven, New York, 1988, pp 435–437.Google Scholar
  437. Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274, 1986.Google Scholar
  438. 438.
    Kanski JJ: Juvenile arthritis and uveitis. Sury Ophthalmol 34: 253, 1990.CrossRefGoogle Scholar
  439. 439.
    Lyne AJ, Rosen ES: Still’s disease and rheumatoid nodules of the sclera. Br J Ophthalmol 52: 853, 1968.PubMedCrossRefGoogle Scholar
  440. 440.
    Watson P: Diseases of the sclera and episclera. In Duane TD, Jaeger EA (Eds): Clinical Ophthalmology, Vol 4. Harper and Row, Philadelphia, 1985, Chap 23.Google Scholar
  441. 441.
    Ide T, Inoue K: Case of unilateral episcleral sarcoid tubercle. Folia Ophthalmologica Japonica 19: 632, 1968.PubMedGoogle Scholar
  442. 442.
    James DG, Anderson R, Langley D, Ainslie D: Ocular sarcoidosis. Br J Ophthalmol 48: 461, 1964.PubMedCrossRefGoogle Scholar
  443. 443.
    Friedman AH, Henkind P: Unusual cases of episcleritis. Trans Am Acad Ophthalmol Otolaryngol 78: 890, 1974.Google Scholar
  444. 444.
    Klein M, Calvert RJ, Joseph WE, Smith E: Rarities in ocular sarcoidosis. Br J Ophthalmol 39: 416, 1955.PubMedCrossRefGoogle Scholar
  445. 445.
    Donaldson DD: Sarcoid nodules of iris and of paralimbal sclera. Arch Ophthalmol 71: 246, 1964.CrossRefGoogle Scholar
  446. 446.
    Zeiter JH, Bhaysar A, McDermott ML, Siegel MJ: Ocular sarcoidosis manifesting as an anterior staphyloma. Am J Ophthalmol 112: 3, 1991.Google Scholar
  447. 447.
    Tabbara KF: Scleromalacia associated with Vogt-Koyanagi—Harada syndrome. Am J Ophthalmol 105: 6, 1988.Google Scholar
  448. 448.
    Sainz de la Maza M, Foster CS: Necrotizing scleritis after ocular surgery: a clinicopathologic study. Ophthalmology 98: 1720, 1991.Google Scholar
  449. 449.
    Mamalis N, Johnson MD, Haines JM, Teske MP, Olson RJ: Corneal-scleral melt in association with cataract surgery and intraocular lenses: a report of four cases. J Cataract Refract Surg 16: 109, 1990.Google Scholar
  450. 450.
    Yang HK, Kline OR Jr: Corneal melting with intraocular lenses. Arch Ophthalmol 100: 1272, 1982.PubMedCrossRefGoogle Scholar
  451. 451.
    Insler MS, Boutros G, Boulware DW: Corneal ulceration following cataract surgery in patients with rheumatoid arthritis. Am Intraocular Implant Soc J 11: 594, 1985.Google Scholar
  452. 452.
    Bloomfield SE, Becker CG, Christian CL, Nauheim JS: Bilateral necrotising scleritis with marginal corneal ulceration after cataract surgery in a patient with vasculitis. Br J Ophthalmol 64: 170, 1980.PubMedCrossRefGoogle Scholar
  453. 453.
    Rao NA, Marak GE, Hidayat AA: Necrotizing scleritis. A clinicopathologic study of 41 cases. Ophthalmology 92: 1542, 1985.PubMedGoogle Scholar
  454. 454.
    Collins DH: The subcutaneous nodule of rheumatoid arthritis. J Pathol Bacteriol 45: 97, 1937.CrossRefGoogle Scholar
  455. 455.
    Bennett GA, Zeller JW, Bauer W: Subcutaneous nodules of rheumatoid arthritis and rheumatic fever: a pathologic study. Arch Pathol 30: 70, 1940.Google Scholar
  456. 456.
    Kaye BR, Kaye RL, Bobrove A: Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases. Am Rheum Dis 23: 345, 1964.CrossRefGoogle Scholar
  457. 457.
    Soter NA, Austen KF: Cutaneous necrotizing venulitis. In Samter M, Talmage DW, Frank MM, Austen KF, Claman HN (Eds): Immunological Diseases. Little, Brown, Boston, 1978, pp 1267–1280.Google Scholar
  458. 458.
    McDuffee FD, Sams WM Jr, Maldonado JE: Hypocomplementemia with cutaneous vasculitis and arthritis: possible immune complex syndrome. Mayo Clin Proc 48: 340, 1973.Google Scholar
  459. 459.
    Lyons CJ, Dart JKG, Aclimandos WA, Light-man S, Buckley RJ: Sclerokeratitis after keratoplasty in atopy. Ophthalmology 97: 729, 1990.PubMedGoogle Scholar
  460. 460.
    Episcleritis and secondary glaucoma after transcleral fixation of a posterior chamber intraocular lens. Arch Ophthalmol 109: 617, 1991.Google Scholar
  461. 461.
    Browning DJ, Proia AD: Ocular rosacea. Surg Ophthalmol 31: 145, 1986.CrossRefGoogle Scholar
  462. 462.
    Osgood JK, Dougherty JM, McCulley JP: The role of wax and sterol esters of meibomian secretions in chronic blepharitis. Invest Ophthalmol Vis Sci 30: 1958, 1989.PubMedGoogle Scholar
  463. 463.
    Borne P: Rosacea with special reference to its ocular manifestations. Br J Dermatol 65: 458, 1953.CrossRefGoogle Scholar
  464. 464.
    Richter S: Skleraperforation bei Rosaceokeratitis. Klin Monatsbl Augenheilk 146: 422, 1965.Google Scholar
  465. 465.
    Hoang-Xuan T, Rodriguez A, Zaltas MM, Rice BA, Foster CS: Ocular rosacea. A histologic and immunopathologic study. Ophthalmology 97: 1468, 1990.PubMedGoogle Scholar
  466. 466.
    Scharf J, Nahir M, Sharf J: Scleritis associated with hyperuricaemia. Rheumatol Tindall 14: 251, 1975.CrossRefGoogle Scholar
  467. 467.
    McWilliams JR: Ocular findings in gout. Am J Ophthalmol 35: 1778, 1952.PubMedGoogle Scholar
  468. 468.
    Wood DJ: Inflammatory disease in the eye caused by gout. Br J Ophthalmol 20: 510, 1936.PubMedCrossRefGoogle Scholar
  469. 469.
    Heinz K: Ocular findings in cases of gout and hyperuricemia. Wien Klin Wochenschr 83: 42, 1971.PubMedGoogle Scholar
  470. 470.
    Fishman RS, Sunderman FW: Band keratopathy in gout. Arch Ophthalmol 75: 367, 1966.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • C. Stephen Foster
    • 1
  • Maite Sainz de la Maza
    • 2
  1. 1.Harvard Medical School, Immunology and Uveitis ServiceMassachusetts Eye and Ear InfirmaryBostonUSA
  2. 2.Central University of BarcelonaBarcelonaSpain

Personalised recommendations